Clinical trial reportNature medicinePublished
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial
12 of 32 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Nature medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm, Residual; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Treatment Outcome; Adult; Aged; Middle Aged; Female; Male
- PubMed ID
- 42350642
- PubMed Central ID
- PMC13375549
- Open access
- Yes, open
- Added to directory
- Source checked